含有瓦洛辛的蛋白质 (VCP):神经退行性疾病的发起者,修饰者和潜在的药物标
Siwei Chu1, Xinyi Xie1, Carla Payan1
1Department of Physiology, McGill University, Montreal, HG3 1Y6, Canada.
Molecular neurodegeneration
|August 6, 2023
概括
含有瓦洛辛的蛋白质 (VCP) 对于神经系统的健康至关重要,清除蛋白质聚合物和受损的器官. VCP突变与神经退行有关,强调其作为药物点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 含有瓦洛辛的蛋白质 (VCP) 是一个AAA+ ATPase,对细胞和器官平衡至关重要,特别是在神经系统中.
- VCP 在复杂的网络中起作用,与辅助因子合作,在各种条件下维持蛋白质稳定.
- 病毒基因突变与许多人类疾病有关,这强调了它在健康中的关键作用.
研究的目的:
- 审查VCP功能障碍和神经退行症之间的关联.
- 讨论当前关于VCP在脑病理中的作用的见解.
- 探索VCP作为神经退行性疾病的潜在治疗点.
主要方法:
- 文献综述侧重于VCP功能,突变和神经退行.
- 对VCP的细胞机制和细胞类型特异性的新兴证据的分析.
- 综合有关VCP在蛋白质聚合物和器官清除中的作用的当前知识.
主要成果:
- VCP对于拆解蛋白质聚合物和去除功能障碍的有机细胞至关重要,对于预防神经功能障碍至关重要.
- VCP突变与神经退行性疾病的发病和进展有关.
- 在多个层面上,VCP调节细胞功能,具有细胞类型特异性的效果,其突变可以破坏平衡.
结论:
- VCP在维持细胞平衡中发挥着多方面的作用,特别是在神经系统中.
- 了解将VCP突变与大脑病理联系起来的分子机制是一个活跃的研究领域.
- 在神经退行性疾病中,VCP是一个有前途的治疗点.
更多相关视频
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
10.7K
11:12Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
7.3K
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
02:58Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K